List of Publications -2016

1421.    Dinesh S, Menon T, Hanna LE, Suresh V, Sathuvan M, Manikannan M. In vitro anti-HIV-1 activity of fucoidan from Sargassum swartzii. Int J Biol Macromol. 2016;82:83-88. (Int J Biological Macromolecules)       

        

1422.    Kumar NP , Banurekha VV, D ina N, Babu S . Circulating angiogenic factors as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.   PLoS One.2016;11(1):e0146318.         

 

1423.    Anuradha R , S aravanan M, Y ukthi B, Jagannathan J , Dolla C , Kumaran P , Nutman TB , Babu S . IL-10- and TGF-mediated Th9 responses in a human helminth infection. PLoS Negl Trop Dis. 2016;10(1):e0004317.     

 

1424.    Thomas BE , B anurekha VV, K annan T, Dina N, Barman SB , Jayabal L , Ovung S , Swaminathan S . Perceptions of private medical practitioners on tuberculosis notification: A study from Chennai, south India. PLoS One. 2016;11(1):e0147579.                     

1425.   Prabhavathi M, Kabeer BS, Anbarasu D, Raja A. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects. Tuberculosis (Edinb).2016;96:27-30.         

 

1426.    Hilda JN , Das SD . TLR stimulation of human neutrophils lead to increased release of MCP-1, MIP-1a, IL-1, IL-8 and TNF during tuberculosis. Hum Immunol. 2016; 77(1):63-67.                 

 

1427.   Kolappan C, Subramani R, Swaminathan S. General and tuberculosis mortality in two states of India: A population-based survey . Indian J Tuberc.2016; 63(1):28-33.

 

1428.    Thomas BE , P oonguzhali S, M uniyandi M, Ovung S , C handra S, Ramnath S, S rividya A, K arikalan N. Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: A systematic review. Plos One. 2016;11(1): e0147397.

 

1429.    Suba S , Kannan P , Gupta UD , Gupta P , Narayanan S . Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs. Vaccine. 2016;34(6):735-743.

 

1430.   Anuradha R, Munisankar S, Bhootra Y, Jagannathan J, Dolla CK, Kumaran P, Shen K, Nutman TB, Babu S . Systemic cytokine profiles in Strongyloides stercoralis infection and alterations following treatment. Infect Immun.2 016;84(2):425-431.   

1431.    Kumar NP, Kadar M, George PJ, Dolla CK, Kumaran P, Babu S . Coincident diabetes mellitus modulates Th1-, Th2- and Th17-cell responses in latent tuberculosis in an IL-10- and TGF--dependent manner. Eur J Immunol .2016;46(2):390-399.  

1432.    Narender M, Jaswanth SB, Umasankar K, Malathi J, Raghuram Reddy A, Umadevi KR , Azger D, Venkat Rao K, Raghuram RA. Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5] thieno[2,3-d]pyrimidin-4(3H)-one schiff bases. Bioorg Med Chem Lett .2016;26(3): 836-840.           

 

1433.    Gupte A , Padmapriyadarsini C , Mave V , Kadam D , Suryavanshi N , Shivakumar SV , Kohli R , Gupte N , Thiruvengadam K , Kagal A , Meshram S , Bharadwaj R , Khadse S S , Ramachandran G , Hanna LE , Pradhan N , Gomathy NS , DeLuca A , Gupta A , Swaminathan S ; CTRIUMPH Study Team . Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study. BMJ Open. 2016;6(2):e010542.     

 

1434.   Kumar NP, Din a N, Banurekha VV , Dolla C K, Kumaran P , Sridhar R , Babu S . Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines. Cytokine. 2016;79:74-81.   

 

1435.      Anuradha R , Munisankar S , Dolla C K, Kumaran P , Nutman TB , Babu S . Modulation of CD4 + and CD8 + T cell function by Interleukin 19 and Interleukin 24 during filarial infections. J Infect Dis. 2016;213(5):811-815.       

 

1436.    Kumar NP , K adar M, George PJ , Dolla C K, Kumaran P , Babu S . Impaired cytokine but enhanced cytotoxic marker expression in Mycobacterium tuberculosis - induced CD8 + T cells in individuals with Type 2 diabetes and latent Mycobacterium tuberculosis infection. J Infect Dis. 2016;213(5):866-870.     

 

1437.   Harishankar M, Anbalagan S, Selvaraj P. Effect of vitamin D 3 on chemokine levels and regulatory T-cells in pulmonary tuberculosis. Int Immunopharmacol.2016;34: 86-91.                

 

1438.    Lienhardt C, Lönnroth K, Menzies D, Balasegaram M, Chakaya J, Cobelens F, Cohn J, Denkinger CM, Evans TG, Källenius G, Kaplan G, Kumar AM, Matthiessen L, Mgone CS, Mizrahi V, Mukadi YD, Nguyen VN, Nordström A, Sizemore CF, Spigelman M, Squire SB, Swaminathan S, Van Helden PD, Zumla A, Weyer K, Weil D, Raviglione M. Translational research for tuberculosis elimination: Priorities, challenges and actions. PLoS Med .2016;13(3):e1001965.

 

1439.    Gupta A , Mathad JS , Abdel-Rahman SM , Albano JD , Botgros R , Brown V , Browning RS , Dawson L , Dooley KE , Gnanashanmugam D , Grinsztejn B , Hernandez-Diaz S , Jean-Philippe P , Kim P , Lyerly AD , Mirochnick M , Mofenson LM , Montepiedra G , Piper J , Sahin L , Savic R , Smith B , Spiegel H , Swaminathan S , Watts DH , White A . Toward earlier inclusion of pregnant and postpartum women in tuberculosis drug trials: Consensus Statements from an International Expert Panel. Clin Infect Dis. 2016 62(6):761-769.               

 

1440.   Unissa AN, Hanna LE, Swaminathan S. A note on derivatives of Isoniazid, Rifampicin and Pyrazinamide showing activity against resistant Mycobacterium tuberculosis . Chem Biol Drug Des. 2016 ;87(4):537- 5 50.     

 

1441.    Anuradha R , Munisankar S , Bhootra Y , Kumar NP , Dolla C , Kumaran P , Babu S . Coexistent malnutrition is associated with perturbations in systemic and antigen - specific cytokine responses in latent tuberculosis infection. Clin Vaccine Immunol. 2016;34(4):339-345.         

 

1442.   Narendran G, Swaminathan S. TB-HIV co-infection: a catastrophic comradeship. Oral Dis.2016;22(Suppl 1):46-52.           

 

1443.    Srivastava S , Pasipanodya JG , Ramachandran G , Deshpande D , Shuford S , Crosswell HE , Cirrincione KN , Sherman CM , Swaminathan S , Gumbo T . A long-term co-perfused disseminated tuberculosis-3D liver hollow fiber model for both drug efficacy and hepatotoxicity in babies. EBioMedicine. 2016;6:126-138.

 

144 4.   Wallis RS, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori GB, Marais B, Schito M, Churchyard G, Swaminathan S, Hoelscher M, Zumla A. Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers . Lancet Infect Dis .2016;16(4):e34-46.    

 

1445.   Kolappan C, Subramani R, Swaminathan S. Tuberculosis mortality in a rural population from south India. Indian J Tuberc.2016;63(2):100-105.

 

1446.   Bibha M, Prabhdeep K , Sudha R. Rao , Sriram S . Non-communicable disease comorbidities and risk factors among tuberculosis patients, Meghalaya, India. Indian J Tuberc.2016;63(2):123-125     

      

1447.    Manikandan M, Kazibwe Z, Hasan N, Anbarasu D, Gopal J, Pradeep T, Chun S. Biological desorption electroscopy ionization mass spectrometry (DESI MS) unequivocal role of crucial ionization factors, solvent system and substrates. TrAC Trends in Analytic Chem;2016;78:109-119.     

 

1448.   Ponnuraja C, Lakshmanan BC, Valarmathi S. Performance accuracy between classifiers in sustain of diseae conversion for clinical trial tuberculosis data: Data mining approach. IOSR J Dental and Med Sci.2016;15(4):105-111.

 

1449.   Desikan P, Chauhan DS, Sharma P, Panwalkar N, Chourey M, Patidar ML, Yadav P, Chandrasekaran V , Ohri BS. Genetic diversity of Mycobacterium tuberculosis isolates from central India. Indian J Med Res.2016;143(4):481-486.     

 

1450.    Ramachandran G , Kumar AK , Kannan T , Bhavani PK , Kumar RS , Gangadevi NP ,   Banurekha VV , Sudha V , Venkatesh S , Ravichandran N , Kalpana S , Mathevan G , Sanjeeva GN , Agarwal D , Swaminathan S . Low serum concentrations of Rifampicin and Pyrazinamide associated with poor treatment outcomes in children with tuberculosis related to HIV status. Pediatr Infect Dis J .2016;35(5):530-534.

 

1451.    Santhi D, Raja A . Variable transcriptional adaptation between the laboratory (H37Rv) and clinical strains (S7 and S10) of Mycobacterium tuberculosis under hypoxia. Infect Genet Evol. 2016;40:21-28.

 

1452. Unissa AN, Sameer H, Indira Kumari V, Revathy R, Hanna LE. Insights into RpoB clinical mutants in mediating rifampicin resistance in Mycobacterium tuberculosis. J Mol Graph Model.2016;67:20-32.

1453. Mave V, Chandanwale A, Kinikar A, Khadse S, Kaga, A, Gupte N, Suryavanshi N, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Joshi S, Horng H, Benet LZ, Ramachandran G, Dooley KE, Gupta A, Gandhi M. Isoniazid hair concentrations in children with tuberculosis: a proof of concept study. Int J Tuberc Lung Dis.2016;20(6):844-847.

1454. Harishankar M, Selvaraj P. Regulatory role of Cdx-2 and Taq I polymorphism of Vitamin D Receptor gene on chemokine expression in pulmonary tuberculosis. Hum Immunol.2016;77(6):498-505.          

1455.   Balaji P, Prabhavathi M, Anbarasu D, Pugazhvanthen P, Raja A. Dynamic IgG antibody response to immunodominant antigens of M. tuberculosis for active TB diagnosis in high endemic settings. Clin Chim Acta. http://www.ncbi.nlm.nih.gov/pubmed/27370403 2016;461:25-33.

 

1456.   Hemanth Kumar AK, Sudha V, Leelavathi A, Geetha Ramachandran. A rapid isocratic high performance liquid chromatography (HPLC-UV) method for the quantification of ritonavir in human plasma. Int J Pharm Pharmaceut Sci.2016; 8(7): 64-68.                   

 

1457.     Afsal K, Selvaraj P. Effect of 1,25-dihydroxyvitamin D 3 on the expression of mannose receptor, DC-SIGN and autophagy genes in pulmonary tuberculosis. Tuberculosis.2016;99:1-10.           

 

1458.   Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition & tuberculosis in India: Situation analysis and the way forward. Indian J Med Res.2016;144:11-20.             

 

1459.   Subramani R, Gomathy S, Lakshmi M, Swaminathan S. Trend in the incidence of smear-positive tuberculosis in a district in south India after DOTS implementation . Int J Tuberc Lung Dis.2016;8(1): 1022-1026.         

1460.    Shainaba SA , Sameer H, Hanna LE , Uma Devi R, Vanaja K. Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A. J Mol Model. 2016;22(8):180.         

 

1461.   GBD 2015 HIV Collaborators, Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, Hay SI, Mills EJ, Trickey A, Msemburi W, Coates MM, Mooney MD, Fraser MS, Sligar A, Salomon J, Larson HJ, Friedman J, Abajobir AA, Abate KH, Abbas KM, Razek MM, Abd-Allah F, Abdulle AM, Abera SF, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Abyu GY, Adebiyi AO, Adedeji IA, Adelekan AL, Adofo K, Adou AK, Ajala ON, Akinyemiju TF, Akseer N, Lami FH, Al-Aly Z, Alam K, Alam NK, Alasfoor D, Aldhahri SF, Aldridge RW, Alegretti MA, Aleman AV, Alemu ZA, Alfonso-Cristancho R, Ali R, Alkerwi A, Alla F, Mohammad R, Al-Raddadi S, Alsharif U, Alvarez E, Alvis-Guzman N, Amare AT, Amberbir A, Amegah AK, Ammar W, Amrock SM, Antonio CA, Anwari P, Ärnlöv J, Artaman A, Asayesh H, Asghar RJ, Assadi R, Atique S, Atkins LS, Avokpaho EF, Awasthi A, Quintanilla BP, Bacha U, Badawi A, Barac A, Bärnighausen T, Basu A, Bayou TA, Bayou YT, Bazargan-Hejazi S, Beardsley J, Bedi N, Bennett DA, Bensenor IM, Betsu BD, Beyene AS, Bhatia E, Bhutta ZA, Biadgilign S, Bikbov B, Birlik SM, Bisanzio D, Brainin M, Brazinova A, Breitborde NJ, Brown A, Burch M, Butt ZA, Campuzano JC, Cárdenas R, Carrero JJ, Castañeda-Orjuela CA, Rivas JC, Catalá-López F, Chang HY, Chang JC, Chavan L, Chen W, Chiang PP, Chibalabala M, Chisumpa VH, Choi JY, Christopher DJ, Ciobanu LG, Cooper C, Dahiru T, Damtew SA, Dandona L, Dandona R, das Neves J, de Jager P, De Leo D, Degenhardt L, Dellavalle RP, Deribe K, Deribew A, Des Jarlais DC, Dharmaratne SD, Ding EL, Doshi PP, Driscoll TR, Dubey M, Elshrek YM, Elyazar I, Endries AY, Ermakov SP, Eshrati B, Esteghamati A, Faghmous ID, Farinha CS, Faro A, Farvid MS, Farzadfar F, Fereshtehnejad SM, Fernandes JC, Fischer F, Fitchett JR, Foigt N, Fullman N, Fürst T, Gankpé FG, Gebre T, Gebremedhin AT, Gebru AA, Geleijnse JM, Gessner BD, Gething PW, Ghiwot TT, Giroud M, Gishu MD, Glaser E, Goenka S, Goodridge A, Gopalani SV, Goto A, Gugnani HC, Guimaraes MD, Gupta R, Gupta R, Gupta V, Haagsma J, Hafezi-Nejad N, Hagan H, Hailu GB, Hamadeh RR, Hamidi S, Hammami M, Hankey GJ, Hao Y, Harb HL, Harikrishnan S, Haro JM, Harun KM, Havmoeller R, Hedayati MT, Heredia-Pi IB, Hoek HW, Horino M, Horita N, Hosgood HD, Hoy DG, Hsairi M, Hu G, Huang H, Huang JJ, Iburg KM, Idrisov BT, Innos K, Iyer VJ, Jacobsen KH, Jahanmehr N, Jakovljevic MB, Javanbakht M, Jayatilleke AU, Jeemon P, Jha V, Jiang G, Jiang Y, Jibat T, Jonas JB, Kabir Z, Kamal R, Kan H, Karch A, Karema CK, Karletsos D, Kasaeian A, Kaul A, Kawakami N, Kayibanda JF, Keiyoro PN, Kemp AH, Kengne AP, Kesavachandran CN, Khader YS, Khalil I, Khan AR, Khan EA, Khang YH, Khubchandani J, Kim YJ, Kinfu Y, Kivipelto M, Kokubo Y, Kosen S, Koul PA, Koyanagi A, Defo BK, Bicer BK, Kulkarni VS, Kumar GA, Lal DK, Lam H, Lam JO, Langan SM, Lansingh VC, Larsson A, Leigh J, Leung R, Li Y, Lim SS, Lipshultz SE, Liu S, Lloyd BK, Logroscino G, Lotufo PA, Lunevicius R, Razek HM, Mahdavi M, Majdan M, Majeed A, Makhlouf C, . Swaminathan S, et al . Estimates of global, regional and national incidence, prevalence and mortality of HIV, 1980-2015; the global burden of disease study 2015.Lancet;2016;3(8):e361-387.  

                     

1462.   Ramesh K, Hemanth Kumar AK, Kannan T,  Vijayalakshmi R, Sudha V, Manohar Nesakumar S, Bharathiraja T, Lavanya J, Swaminathan S, Ramachandran G. SLCO1B1 gene polymorphisms do not influence plasma rifampicin concentrations in a south Indian population. Int J Tuberc Lung Dis;2016;20(9) 1231-1235.

 

1463.   Hemanth Kumar AK, Kannan T, Chandrasekaran V, Sudha V, Vijayakumar A, Ramesh K, Lavanya J, Swaminathan S, Ramachandran G. Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India. Int J Tuberc Lung Dis.2016;20(9) 1236-1241.       

 

1464.   Refaya AK, Sharma D, Kumar V, Bisht D, Narayanan S. A Serine/threonine kinase PknL, is involved in the adaptive response of Mycobacterium tuberculosis . Microbiol Res.2016;190:1-11.             

 

1465.    Kumar NP , Kadar M, V ijay V, Kornfeld H , Babu S . Effect of standard tuberculosis treatment on naive, memory and regulatory T cell homeostasis in tuberculosis -diabetes co-morbidity. Immunology.2016;149(1):87-97.     

 

1466.    Sundaramurthi JC, Hanna LE, Sriram S, Brindha S, Joel Gnanadoss J, Savariar V, Harpreet S, Swaminathan S. TBDRUGS - Database of drugs for tuberculosis. Tuberculosis;2016;100:69-71.         

  

1467.   Babu S, Nutman TB. Helminth-Tuberculosis co-infection: An immunologic perspective. Trends Immunol.2016;37(9):597-607.       

1468.    D ina N, Rajshekhar N , Klinton JS , Watson B , Banurekha VV, Tripathy JP , Jawahar MS , Swaminathan S . Household contact screening and yield of tuberculosis cases - A clinic based study in Chennai, south India. PLOS One.2016;11(9):e0162090.

 

1469.   Dinesh Kumar P, Sameer H, Narayanan S. M ultifaced pknE: Apoptosis inhibition, HIV co-Infection, host signaling cross-talk and in orchestrating the physiology of M. tuberculosis. J Microb Biochem Technol.2016;8:3.       

 

1470.    Narendran G , Kavitha D , R amesh K, Gil-Santana L , Almeida-Junior JL , Reddy SD , M akesh Kumar, Hemalatha H , Jayanthi NN , Ravichandran N , Krishnaraja R , Prabhakar A , Manoharan T , Nithyananthan L , G unasunari A, M ohan N, Swaminathan S , Andrade BB . Role of LTA4H polymorphism in tuberculosis-associated immune reconstitution inflammatory syndrome occurrence and clinical severity in patients infected with HIV. PLoS One. 2016;11(9):e0163298.   

 

1471.   Narendran G, Padmapriyadarsini C, Swaminathan S, Tripathy S. Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis. AIDS Res Ther .2016;13(1):34.               

 

1472.   Dina N, Gangadevi NP , Tripathy JP, Harries AD, Klinton JS, Watson B, Gomathi NS, Reddy DS, Lakshmi M, Mohan N, Swaminathan S. Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant TB, Tamil Nadu, India. Trans R Soc Trop Med Hyg .2016;110(9): 534-541.               

 

1473.   Unissa AN, Selvakumar S, Hanna LE , Selvakumar N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evol . 2016;45:474-492.               

 

1474.   Balaji S, Kumar V, Prabu S, Radhakrishnan R, Gomathi S, Kannan T, Chandrasekaran V, Swaminathan S, Selvakumar N. Adequacy of examining one sputum specimen in tuberculosis drug resistance surveys . Int J Mycobacteriol.2016; 5(3):265-268.               

1475.   Santhi D, A kilandeswari G, Das SD , Raja A . Proteomics analysis of three different strains of Mycobacterium tuberculosis under in vitro hypoxia and evaluation of hypoxia associated antigen's specific memory T cells in healthy household contacts. Front Microbiol.2016;7:Article 1275.             

 

1476.    Ashokkumar M , Tripathy SP , Hanna LE . Variability in V1V2 and PNGs in pediatric HIV-1 viral variants transmitted through vertical route. AIDS Res Hum Retroviruses. 2016;32(10-11):942-943.         .   

 

1477.    Aralaguppe SG , Siddik AB , A shokkumar M, Ambikan AT , Kumar MM , Fernandes SJ , Amogne W , Bangaruswamy DK , Hanna LE , Sonnerborg A , Neogi U . Multiplexed next-generation sequencing and de novo assembly to obtain near full-length HIV-1 genome from plasma virus. J Virol Methods. 2016;236:98-104.   

 

1478.   Kumar E, Muthuvijayalakshmi M, Ravanan R. Disease diagnosis by using Cox PH and frailty models. Int J Sci Res.2016;5(10)354-358.

1479. Subbaraman R, Nathavitharana RR, Satyanarayana S, Pai M, Thomas BE, Chadha VK, Rade K, Swaminathan S, Mayer KH. The Tuberculosis cascade of care in India's public sector: A systematic review and meta-analysis. PLoS Med.2016;13(10): e1002149.

 

1480.   Cheekatla SS, Tripathi D, Venkatasubramanian S, Nathella PK, Paidipally P, Ishibashi M, Welch E, Tvinnereim AR, Ikebe M, Valluri VL, Babu S , Kornfeld H, Vankayalapati R. NK-CD11c+ cell crosstalk in diabetes enhances IL-6-mediated inflammation during Mycobacterium tuberculosis infection. PLoS Pathog .2016; 12(10):e1005972.               

 

1481.    Arunkumar V, Kannan P, Sharma D, Deepa B, Narayanan S. Functional characterization of PknI-Rv2159c interaction in Redox Homeostasis of Mycobacterium tuberculosis . Frontiers in Microbiol.2016;7: Article 1654.

 

1482.    Swaminathan S , Pasipanodya JG , Ramachandran G , Hemanth Kumar AK , Srivastava S , Deshpande D , Nuermberger E , Gumbo T . Drug concentration thresholds predictive of therapy failure and death in children with tuberculosis: bread crumb trails in random forests. Clin Infect Dis.2016;63(suppl 3):S63-S74.     

 

1483.    Srivastava S , Deshpande D , Pasipanodya JG , Thomas T , Swaminathan S , Nuermberger E , Gumbo T . A combination regimen design program based on pharmacodynamic target setting for childhood tuberculosis: Design rules for the playground. Clin Infect Dis.2016;63(suppl 3):S75-S79.     

 

1484.   Deshpande D, Srivastava S , Pasipanodya JG , Bush SJ, Nuermberger E , Swaminathan S, Gumbo T. Linezolid for infants and toddlers with disseminated tuberculosis: First steps. Clin Infect Dis.2016;63(suppl 3):S80-S87.       

 

1485.    Deshpande D , Srivastava S , Nuermberger E , Pasipanodya JG , Swaminathan S , Gumbo T . Concentration-dependent synergy and antagonism of linezolid and Moxifloxacin in the treatment of childhood tuberculosis: The dynamic duo. Clin Infect Dis. 2016;63(suppl 3):S88-S94.           

 

1486.   Deshpande D, Srivastava S, Nuermberger E, Pasipanodya JG, Swaminathan S, Gumbo T. A Faropenem, Linezolid, and Moxifloxacin regimen for both drug-susceptible and multidrug-resistant tuberculosis in children: FLAME path on the milky way. Clin Infect Dis .2016;63(suppl 3):S95-S101.     

 

1487.   Srivastava S, Deshpande D, Pasipanodya J, Nuermberger E, Swaminathan S, Gumbo T. Optimal clinical doses of Faropenem, Linezolid, and Moxifloxacin in children with disseminated tuberculosis: Goldilocks. Clin Infect Dis .2016;63(suppl 3):S102-S109.

 

1488.    Santhi D, Raja A. T-cell recall response of two hypothetical proteins (Rv2251 and Rv2721c) from Mycobacterium tuberculosis in healthy household contacts of TB - possible subunit vaccine candidates. J Infect .2016;73(5):455-467.   

 

1489.   Balaji P, Ramalingam B. Biomarker and therapeutic targets for tuberculosis: Role of micro RNAs. J Investigative Genomics.2016;3(3): 1-5.     

 

1490.   Swaminathan S, Sundaramurthi JC, Natarajan PL, Narayanan S. Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis. Tuberculosis.2016;101:31-40.         

    

1491.   Banurekha VV, Dina N, Kannan T , Padmapriyadarsini C, Sachdeva KS, Bency J, Klinton JS, Haldar S, Khanna A, Jayasankar S, Swaminathan S. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis. Int J Tuberc Lung Dis.2016; 20(12): 1671-1676.          

 

1492.    Anuradha R , Munisankar S , Bhootra Y , Dolla C , Kumaran P , Babu S . High body mass index is associated with heightened systemic and mycobacterial antigen - Specific pro-inflammatory cytokines in latent tuberculosis. Tuberculosis (Edinb). 2016;101:56-61.               

 

1493.    Kumar NP , Moideen K , Sivakumar S , Menon PA , V ijay V, Kornfeld H , Babu S . Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment. Tuberculosis.(Edinb). 2016; 101:191-200.                 

 

1494.    Padmapriyadarsini C , D ina N, Gomathi NS , Banurekha VV. Pulmonary Mycobacterium kansasii disease in immunocompetent host: Treatment outcomes with short-course chemotherapy. Indian J Med Microbiol.2016;34(4):516-519.

 

1495.   Rathinasabapati R, Amudhavalli A. National Institute for Research in Tuberculosis (NIRT) Institutional Repository. Asian J Lib Inf.2016;7(3-4):25-32.

 

 

 


2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016